InvestorsHub Logo
Followers 64
Posts 6681
Boards Moderated 2
Alias Born 02/07/2013

Re: SmurfVA post# 804

Tuesday, 02/04/2014 10:28:27 AM

Tuesday, February 04, 2014 10:28:27 AM

Post# of 6939
IGXT ($0.93) HOLD - CRL wasn't bad IMO. FDA's letter accepted the bioequivalence study and safety information submitted and requires no additional clinical studies; IntelGenx and RedHill plan to address remaining issues, primarily related to third party manufacturing, packaging and labeling...etc.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.